1089P Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 7-y results from CheckMate 238Paolo A. Ascierto, James Larkin, Barbara Merelli et al.|Annals of Oncology|2023Cited by 9